Pharma Law USA
Benjamin Fuller of Cornerstone Research will discuss the 340B drug program at this conference hosted by Informa Connect in Boston.
Health Insurance Antitrust Matter
This matter considered competition in the healthcare industry and the legality of certain contracting practices.
Our Curious Amalgam: How Do We Measure Innovation?
In an American Bar Association podcast, Penka Kovacheva of Cornerstone Research discussed how M&A affects innovation in the pharmaceutical industry.
ASHEcon 2024: The Annual Conference of the American Society of Health Economists
Cornerstone Research staff and affiliated experts will speak at this annual conference hosted by the American Society of Health Economics.
2024 Antitrust in Healthcare
Anup Malani of the University of Chicago and James Lee of Cornerstone Research will discuss competition issues in healthcare and life sciences at this American Bar Association conference.
Promoting Competition in Artificial Intelligence
Ben Handel of the University of California, Berkeley will discuss competition and AI industry structure in healthcare at this virtual workshop hosted by the Department of Justice and Stanford University.
Ciccio et al. v. SmileDirectClub LLC et al.
Class certification was denied in this false advertising matter.
5 Questions with Sayeh Nikpay: The 340B Drug Pricing Program
Professor Sayeh Nikpay of the University of Minnesota discusses the role and implementation challenges of the 340B Drug Pricing Program.
Q&A with Joanna Tsai
WWL interviewed Joanna Tsai of Cornerstone Research about working at the FTC, the evolution of merger analysis, and her advice for aspiring competition economists.
Cross-Market Implications in FTC’s Anesthesia Complaint
The authors discuss how precedents from this case could potentially provide a framework under which the FTC will challenge mergers.
How can we help you?
If you are looking for a publication not on our website, contact us.